Foundational Science and Mechanisms of Disease

A 68-year-old man is admitted to the hospital with a 3-week history of low-grade fevers, chills, and generalized fatigue. He recently underwent a cystoscopy for benign prostatic hyperplasia. On physical examination, his temperature is 38.2°C (100.8°F), and a new holosystolic murmur is heard at the cardiac apex. Blood cultures grow gram-positive cocci in pairs and short chains that are catalase-negative and grow in 6.5% NaCl broth. Transesophageal echocardiography reveals a 1.2-cm vegetation on the mitral valve.

The patient is started on continuous-infusion ampicillin and once-daily gentamicin to achieve synergistic bactericidal activity. Two days later, antimicrobial susceptibility testing results are reported as follows:

Given these results, gentamicin is discontinued, and ceftriaxone is added to the ampicillin regimen. Which of the following best describes the precise molecular mechanism responsible for the lack of ampicillin-gentamicin synergy in this patient's isolate?

A 54-year-old woman is evaluated in the intensive care unit for worsening respiratory status. She was admitted 14 days ago for management of extensive third-degree burns covering 40% of her total body surface area. Over the past 24 hours, she has developed a new-onset fever, tachycardia, and increased purulent endotracheal secretions requiring higher ventilator settings. Her temperature is 39.4°C (102.9°F), blood pressure is 90/55 mmHg, and heart rate is 118/min. A Gram stain of the endotracheal aspirate reveals numerous neutrophils and Gram-negative bacilli. The organism is non-lactose-fermenting, oxidase-positive, and produces a blue-green pigment on culture. Antimicrobial susceptibility testing results for the isolate are shown below:

Which of the following cellular mechanisms best explains this isolate's specific antimicrobial resistance profile?

During a routine health maintenance examination, a physician palpates an asymptomatic, firm nodule in the right anterior neck of an adult female patient. The patient denies any recent weight changes, palpitations, dysphagia, or hoarseness. Her vital signs are within normal limits.

Laboratory evaluation reveals a serum thyroid-stimulating hormone (TSH) level of $2.1 \text{ mIU/L}$ (normal: $0.4 - 4.0 \text{ mIU/L}$) and a free T4 of $1.3 \text{ ng/dL}$ (normal: $0.9 - 1.7 \text{ ng/dL}$).

A dedicated neck ultrasound demonstrates a $1.8\text{-cm}$ solid, hypoechoic nodule in the right thyroid lobe with irregular margins and punctate microcalcifications. A subsequent fine-needle aspiration biopsy is performed, revealing clusters of cells that demonstrate pale, empty-appearing nuclei, prominent longitudinal nuclear grooves, and scattered laminated calcific spherules.

Based on the confirmed diagnosis, which of the following correctly pairs the predominant molecular pathogenesis of this patient's neoplasm with a principle of its clinical management?

A 71-year-old man with a history of permanent atrial fibrillation is maintained on a novel oral anticoagulant (NOAC) at a standard daily dose to prevent thromboembolism. The NOAC has a baseline oral bioavailability ($F$) of $30\%$, is a known substrate of intestinal P-glycoprotein (P-gp) efflux pumps, and undergoes extensive hepatic elimination via the cytochrome P450 3A4 (CYP3A4) pathway. The baseline elimination half-life ($t_{1/2}$) of this medication is 10 hours.

The patient is recently diagnosed with a systemic fungal infection and is started on oral itraconazole, a potent dual inhibitor of both P-gp and CYP3A4. Co-administration of itraconazole increases the NOAC's oral bioavailability to $90\%$ and reduces its hepatic clearance ($CL$) by $50\%$.

One week later, the patient presents to the emergency department with severe gastrointestinal hemorrhage and requires urgent resuscitation. Assuming the volume of distribution ($V_d$) remains constant, which of the following accurately describes the pharmacokinetic alterations responsible for this patient's presentation?

A 28-year-old woman is brought to the emergency department by her partner due to a painful, blistering skin rash. She has a history of bipolar I disorder with rapid cycling. For the past year, her psychiatric regimen consisted solely of lamotrigine, but due to poor mood control, her psychiatrist added a second medication 4 weeks ago. Two days ago, the patient developed a fever, malaise, and a sore throat. This morning, a diffuse erythematous maculopapular rash appeared on her face and trunk, which has rapidly progressed to form flaccid blisters with mucosal involvement. A dermatologist is consulted and suspects Stevens-Johnson syndrome. Laboratory studies reveal a significantly supratherapeutic serum lamotrigine concentration. The psychiatric medication added 4 weeks ago most likely increased this patient's risk for her current condition through which of the following pharmacokinetic mechanisms?

A 45-year-old man with a history of advanced human immunodeficiency virus infection is admitted to the hospital for evaluation of a 4-week history of low-grade fever, drenching night sweats, diffuse abdominal pain, and a 6-kg (13.2-lb) weight loss. He has not been compliant with his antiretroviral therapy. His most recent CD4 T-lymphocyte count is 35 cells/mm³. Laboratory studies show a hemoglobin of 8.2 g/dL and an elevated serum alkaline phosphatase level. Blood cultures obtained using a lysis-centrifugation system grow non-tuberculous acid-fast bacilli. The patient is initiated on a multidrug antimicrobial regimen. Three months later, he returns with recurrent fever, and repeat blood cultures isolate the same pathogen. Susceptibility testing reveals newly acquired high-level resistance to the macrolide component of his regimen. This resistance is most likely mediated by a structural alteration in which of the following cellular targets?

A 68-year-old man is evaluated for progressive headaches and left-sided weakness over the past month. Magnetic resonance imaging of the brain reveals a 4-cm, ring-enhancing lesion in the right frontal lobe with extensive surrounding edema, characteristic of glioblastoma. The patient undergoes surgical resection. Pathologic examination of the tissue demonstrates pseudo-palisading necrosis and prominent microvascular proliferation. The rapid growth and vascularization of this patient's tumor are primarily driven by a cascade of molecular events initiated by the tumor microenvironment. Arrange the following molecular and cellular events in the correct chronological order to describe the mechanism of tumor-induced angiogenesis in this patient.

An inpatient in their sixties is currently receiving treatment on the medical ward for a severe exacerbation of chronic obstructive pulmonary disease. Their therapeutic regimen includes intravenous methylprednisolone, scheduled bronchodilators, and subcutaneous unfractionated heparin for deep venous thrombosis prophylaxis. Upon admission $6$ days ago, their platelet count was $310,000 \text{ /mm}^3$ and hemoglobin was $14.8 \text{ g/dL}$. Today, the patient reports acute, progressive pain in the left lower extremity. Physical examination demonstrates asymmetric swelling, warmth, and tenderness of the left calf. A bedside compression ultrasonography reveals an acute, non-compressible thrombus in the left popliteal vein. Stat laboratory evaluation shows a current platelet count of $145,000 \text{ /mm}^3$, with a normal prothrombin time and activated partial thromboplastin time. Based on the most likely diagnosis, which of the following is the most appropriate next step in the pharmacologic management of this patient?

An 81-year-old male with persistent atrial fibrillation and nonadherence to anticoagulation therapy arrives at the emergency department. He reports severe, generalized abdominal pain that began abruptly two hours ago. On physical examination, the patient exhibits minimal abdominal tenderness despite his severe subjective pain. His pulse is 115/min and irregularly irregular. A CT angiogram demonstrates a large thromboembolus occluding the proximal superior mesenteric artery. The patient is prepped for emergency laparotomy to resect the affected bowel segment. Arrange the following subcellular biochemical events in the correct chronological order, representing the progressive ischemic injury occurring within the affected intestinal epithelial cells.

A 64-year-old man with chronic hepatitis C virus infection is evaluated for abdominal distension, fatigue, and a $5\text{-kg}$ ($11\text{-lb}$) weight loss over the past two months. Three weeks ago, he was admitted to the hospital for an episode of hematemesis. Esophagogastroduodenoscopy at that time revealed large esophageal varices with red wale signs; he received endoscopic band ligation and was discharged on nadolol.

Vital signs today are within normal limits. Physical examination shows scleral icterus, palmar erythema, and a palpable, hard liver edge $4 \text{ cm}$ below the right costal margin.

Laboratory studies show:
Total bilirubin: $2.4 \text{ mg/dL}$
Aspartate aminotransferase (AST): $95 \text{ U/L}$
Alanine aminotransferase (ALT): $88 \text{ U/L}$
Platelet count: $85,000/\mu\text{L}$
Alpha-fetoprotein: $2,100 \text{ ng/mL}$

A multiphase abdominal CT scan reveals a $7\text{-cm}$ hypervascular mass in the right hepatic lobe that demonstrates avid arterial phase enhancement and rapid portal venous washout. The mass invades the right main branch of the portal vein. There is no evidence of extrahepatic metastasis.

The multidisciplinary tumor board considers initiating the preferred first-line systemic combination regimen consisting of atezolizumab and bevacizumab. However, the oncologist determines that this specific regimen is currently contraindicated for this patient.

This contraindication is primarily due to the drug-induced impairment of which of the following physiological processes?

A 65-year-old woman who underwent an uncomplicated total knee arthroplasty two weeks ago collapses suddenly at a rehabilitation center and is transported to the emergency department. On arrival, she is cyanotic and lacks a palpable pulse. The cardiac monitor shows pulseless electrical activity (PEA) at a rate of 110/min. Advanced cardiovascular life support is initiated. A rapid point-of-care echocardiogram obtained during a pulse check reveals a massively enlarged right ventricle, a severely compressed left ventricle, and a plethoric inferior vena cava. Despite aggressive resuscitation with intravenous fluids, epinephrine, and CPR, the patient succumbs. Autopsy confirms a massive saddle pulmonary embolus.

Arrange the following pathophysiological and hemodynamic events in the correct chronological sequence that led to this patient's fatal obstructive shock.

A variety of clinical scenarios demonstrating different forms of cellular responses to stress or injury are presented below. Match each patient presentation to the most precise underlying cellular adaptation or mechanism of cell death.

A 48-year-old woman with a history of injection drug use is admitted to the hospital with high fevers, chills, and pleuritic chest pain. Blood cultures drawn on admission grow methicillin-resistant *Staphylococcus aureus* (MRSA). A transesophageal echocardiogram reveals a $1.6 \text{ cm}$ mobile vegetation on the tricuspid valve. Intravenous vancomycin therapy is initiated. On hospital day 5, the patient's serum creatinine increases from a baseline of $0.7 \text{ mg/dL}$ to $2.2 \text{ mg/dL}$. Due to concern for vancomycin-induced nephrotoxicity, her antimicrobial regimen is switched to intravenous daptomycin. The patient initially defervesces and improves, but $12$ days later, she develops recurrent fevers and bacteremia. Susceptibility testing of the new isolate demonstrates a daptomycin minimum inhibitory concentration (MIC) of $4.0 \text{ } \mu\text{g/mL}$, indicating resistance. Which of the following best describes the molecular mechanism responsible for this pathogen's newly acquired resistance to the current antimicrobial therapy?

Various pharmaceutical agents and microbial toxins exert their effects by disrupting highly specific molecular and genetic processes. Match each clinical presentation or drug-induced adverse effect below with the precise underlying molecular mechanism responsible for its pathogenesis.

Match each clinical pharmacogenomic scenario with its precise underlying genetic and molecular mechanism.

An oncology care team is preparing to initiate induction chemotherapy for a recently admitted patient.

Demographics: $19$-year-old male of Mediterranean descent
Vital Signs: Temperature $37.2^\circ\text{C}$ ($99.0^\circ\text{F}$), HR $98\text{/min}$, BP $118/74\text{ mmHg}$, RR $16\text{/min}$
Physical Exam: Noticeably enlarged, non-tender submandibular and cervical lymph nodes. No hepatosplenomegaly.
Laboratory Findings:
- WBC: $12,500\text{/mm}^3$
- Hemoglobin: $13.8\text{ g/dL}$
- Platelets: $180,000\text{/mm}^3$
- Uric acid: $11.2\text{ mg/dL}$ (Normal: $4.0-8.5\text{ mg/dL}$)
- LDH: $950\text{ U/L}$ (Normal: $140-280\text{ U/L}$)
- Creatinine: $1.1\text{ mg/dL}$

A peripheral blood smear demonstrates numerous medium-sized atypical lymphocytes with vacuolated, deeply basophilic cytoplasm. Cytogenetic analysis confirms a $t(8;14)$ translocation. Given the high proliferation index and elevated baseline uric acid, the patient is at significant risk for an oncologic emergency characterized by massive release of intracellular metabolites. The attending physician recommends administering a recombinant enzyme that converts a relatively insoluble purine degradation product into a highly soluble compound. However, before administration, the physician orders an erythrocyte enzyme assay; if this assay demonstrates a specific underlying deficiency, the recombinant agent is absolutely contraindicated.

Which of the following best explains the pathophysiologic mechanism underlying this absolute contraindication?

A 34-year-old female teacher is evaluated in the urgent care center for a 2-day history of dysuria and increased urinary frequency. She reports no fever, flank pain, nausea, or vaginal discharge. Her medical history is significant for three uncomplicated urinary tract infections over the past year. Her most recent infection occurred three weeks ago and was treated with a 5-day course of ciprofloxacin. Vital signs are within normal limits. Physical examination reveals mild suprapubic tenderness on palpation but no costovertebral angle tenderness. Urinalysis is positive for leukocyte esterase and nitrites. A urine culture subsequently yields >100,000 colony-forming units/mL of Escherichia coli. Susceptibility testing indicates that the isolate is resistant to ciprofloxacin and levofloxacin, but remains susceptible to nitrofurantoin, fosfomycin, and trimethoprim-sulfamethoxazole. Which of the following is the most likely mechanism underlying this pathogen's resistance to the previously prescribed antibiotic?

A 58-year-old man with a history of severe alcohol use disorder presents to the emergency department with sudden-onset, excruciating mid-epigastric pain that radiates to his back. He reports multiple episodes of non-bilious vomiting over the past 12 hours. Vital signs show a heart rate of 115/min and blood pressure of 105/65 mmHg. Physical examination reveals marked epigastric tenderness with guarding, but no rebound tenderness. Laboratory testing demonstrates a serum lipase of 3,800 U/L (normal: 10-140 U/L) and a total serum calcium of 7.0 mg/dL (normal: 8.5-10.5 mg/dL). An albumin level is within normal limits. Which of the following mechanisms of cellular injury best explains the pathogenesis of this patient's hypocalcemia?

A 28-year-old critically ill patient is admitted to the intensive care unit with profound acidemia, hyperglycemia, and elevated serum beta-hydroxybutyrate. The medical team initiates a continuous intravenous infusion of a hormone that binds to a transmembrane receptor with intrinsic enzymatic activity. In addition to halting lipolysis, this intervention aggressively stimulates the storage of glucose as a highly branched polymer in the liver. Arrange the following intracellular signaling events in the correct chronological sequence to describe the hepatocyte response to this continuous infusion.

A 28-year-old man of Mediterranean descent is admitted to the oncology unit for initiation of induction chemotherapy. He was recently diagnosed with a highly aggressive B-cell non-Hodgkin lymphoma characterized by a $t(8;14)$ chromosomal translocation. Baseline laboratory studies show a serum uric acid level of $11.5 \text{ mg/dL}$, lactate dehydrogenase of $1,250 \text{ U/L}$, and a serum creatinine of $1.1 \text{ mg/dL}$. To mitigate the risk of an impending oncologic emergency, the patient is administered a recombinant enzyme therapy that directly degrades uric acid into a highly soluble inactive metabolite. Forty-eight hours later, the patient develops sudden-onset fatigue, scleral icterus, and dark urine. His hemoglobin concentration has decreased from $14.2 \text{ g/dL}$ to $8.4 \text{ g/dL}$. A peripheral blood smear reveals the presence of bite cells. The medication that precipitated this patient's acute deterioration is absolutely contraindicated in individuals who have a primary hereditary inability to synthesize adequate amounts of which of the following molecules?